Navigation Links
AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
Date:10/28/2008

QUEBEC CITY, Oct. 28 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its Senior Vice President and Chief Medical Officer, Paul Blake, MD, will present a company overview at the upcoming Oppenheimer 19th Annual Healthcare Conference on Monday, November 3, 2008 at 8:00 am (Eastern Time), in the Basildon Room of the Waldorf-Astoria Hotel in New York City.

A live webcast of the presentation will be available on AEterna Zentaris' website at http://www.aezsinc.com in the Investors section. A replay will also be available for a period of 30 days on the Company's website.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aezsinc.com.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
2. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
3. AEterna Zentaris to Present at BioContact Quebec on October 2, 2008
4. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
5. AEterna Zentaris Reports Second Quarter 2008 Financial and Operating Results
6. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
7. AEterna Zentaris to Announce Second Quarter 2008 Financial and Operating Results on August 12, 2008
8. AEterna Zentaris Sells Quebec City Building for $7.1 million
9. AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting
10. AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
11. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 22, 2017   iSpecimen ®, the ... Doctors Pathology Service (DPS), a full-service anatomic pathology ... the United States , has joined a program ... Network (DHIN) to make human biospecimens and associated ... novel program, announced in 2015 as a collaboration between ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT announced ... "Company" or "Propellon"), a start-up created by FACIT ... therapeutics. FACIT,s investment, combined with non-dilutive capital, achieves ... The seed funding enables Propellon to accelerate the ... Company for financing and/or entering a strategic partnership ...
(Date:3/22/2017)... ... March 21, 2017 , ... Premier executive recruitment firm, Slone ... Search Firm by Hunt Scanlon Media. , Hunt Scanlon Media is one ... widely referenced global news source in the human capital sector. , “It is a ...
(Date:3/22/2017)... ... , ... Benchworks CEO Thad L. Bench Sr. will participate in ... in San Diego. The event is a gathering of executive leadership from companies in ... Christian Meyer will also participate in the forum. Participants will discuss the future of ...
Breaking Biology Technology:
(Date:3/16/2017)... 2017 CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity ... Used combined in one project, multi-biometric ... ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today announces that ... uncover insights to support its reporting, help direct future campaigns, and ... youth charity will be using Brandwatch Analytics social listening and analytics ... of the topics and issues that are a priority for its ... "Until recently ...
(Date:3/2/2017)... , March 2, 2017 Summary ... to better understand Merck KGaA and its partnering interests ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and ... the partnering activity of one of the world,s leading ... are prepared upon purchase to ensure inclusion of the ...
Breaking Biology News(10 mins):